Search Within

Katherine S Panageas

Formats
  1. Journal Article (320)
  2. Meeting Abstract (181)
  3. Editorial (5)
  4. Research Letter (5)
  5. Correspondence (4)
  6. Review (4)
  7. Book Section (3)
  8. Miscellaneous (1)
Groups
  1. Biostatistics Service (523)
  2. Epidemiology and Biostatistics (523)
  3. Population Sciences Research Program (523)
  4. Department of Medicine (306)
  5. Solid Tumor Oncology Division (264)
  6. GSK Faculty (189)

More Groups

People
  1. Anne Reiner (94)
  2. Jedd Wolchok (92)
  3. Lisa De Angelis (86)
  4. Paul Chapman (77)
  5. Michael Postow (66)
  6. Clifford Hudis (56)

More People

Years
  1. 2025 (19)
  2. 2024 (23)
  3. 2023 (28)
  4. 2022 (28)
  5. 2021 (34)
  6. 2020 (29)

More Years

Publications
  1. Journal of Clinical Oncology (109)
  2. Neuro-Oncology (42)
  3. Clinical Cancer Research (31)
  4. Annals of Surgical Oncology (28)
  5. Cancer (21)
  6. Breast Cancer Research and Treatment (20)

More Publications

Publishers
  1. American Society of Clinical Oncology (122)
  2. Oxford University Press (68)
  3. Springer (65)
  4. American Association for Cancer Research (56)
  5. Wiley Blackwell (38)
  6. American Medical Association (19)

More Publishers

Results (523)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Increased dose-density (DD) is feasible: A pilot study of epirubicin and cyclophosphamide (EC) followed by paclitaxel (T), at 10-11 day interval with filgrastim support, for women with early breast carcinoma (BC)
    Meeting Abstract

    Fornier, M. N.; Seidman, A. D.; Lake, D.; D'Andrea, G.; Bromberg, J.; Robson, M.; Van Poznak, C. H.; Panageas, K.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Rates and predictors of adjuvant chemotherapy use in older breast cancer patients with hormone receptor-negative disease
    Meeting Abstract

    Elkin, E. B.; Panageas, K. S.; Hurria, A.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Prolonged dose-dense (DD) epirubicin and cyclophosphamide (EC) followed by paclitaxel (T) in breast cancer (BCA) is feasible
    Meeting Abstract

    Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Preliminary cardiac safety results of dose-dense (DD) doxorubicin and cyclophosphamide (AC) followed by paclitaxel (T) with trastuzumab (H) in HER2/neu overexpressed/amplified breast cancer (BCA)
    Meeting Abstract

    Dang, C.; Smith, K.; Lake, D.; Fornier, M.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Troso-Sandoval, T.; Sugarman, S.; Gilewski, T.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save
  • Stage specific survival is altered by the changes in the 2002 AJCC staging for melanoma
    Meeting Abstract

    Ben-Porat, L.; Panageas, K. S.; Hanlon, C.; Patel, A.; Houghton, A. N.; Halpern, A. C.; Coit, D. G.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Variates of survival in metastatic uveal melanoma
    Journal Article

    Rietschel, P.; Panageas, K. S.; Hanlon, C.; Patel, A.; Abramson, D. H.; Chapman, P. B.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma
    Journal Article

    Raizer, J. J.; Koutcher, J. A.; Abrey, L. E.; Panageas, K. S.; De Angelis, L. M.; Lis, E.; Xu, S.; Zakian, K. L.
    Journal of Neuro-Oncology (2005)

    Fulltext@MSK | Save
  • Trends in survival from primary central nervous system lymphoma, 1975-1999: A population-based analysis
    Journal Article

    Panageas, K. S.; Elkin, E. B.; De Angelis, L. M.; Ben-Porat, L.; Abrey, L. E.
    Cancer (2005)

    Fulltext@MSK | Save
  • Delayed neurotoxicity in primary central nervous system lymphoma
    Journal Article

    Omuro, A. M. P.; Ben Porat, L. S.; Panageas, K. S.; Kim, A. K.; Correa, D. D.; Yahalom, J.; De Angelis, L. M.; Abrey, L. E.
    Archives of Neurology (2005)

    Fulltext@MSK | Save
  • A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancer
    Journal Article

    Modi, S.; Seidman, A. D.; Dickler, M.; Moasser, M.; D'Andrea, G.; Moynahan, M. E.; Menell, J.; Panageas, K. S.; Tan, L. K.; Norton, L.; more...
    Breast Cancer Research and Treatment (2005)

    Fulltext@MSK | Save